In this interview, we hear from Minna Mattila on the importance of quality control in the development of IVD immunoassays for disease detection, diagnosis, and monitoring
Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?
Explore the importance of the European Pharmacopoeia to pharma manufacturers worldwide, with exclusive insights into the recently released version
Today’s activities are part of ongoing implementation of new authorities for certain over-the-counter drugs
ELRIG’s EDI Guiding Principles promote inclusivity and collaboration in the drug discovery community
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Sunil Patel reveals the key technology behind reliable pharmaceutical formulation and finished product analysis at Intas Pharmaceuticals
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target
Deborah McManus and Gareth Satchell, Drug Development Solutions, LGC
Top talks presenting the latest technologies, research and applications are now available on demand
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines
The kit detects four hazardous Aspergillus species in cannabis flower
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
Company rapidly expanding commercial operations to enable more researchers to extract higher yields of DNA and RNA from FFPE samples in one hour with minimal hands-on time
